Prevent Announces Management Changes and Termination of Services of CFO and VP Finance and Communications

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

CALGARY, AB / ACCESSWIRE / May 17, 2019 / Calgary, AB: Prevent Health Care International Corp. (the “Corporation“) today announced that it has commenced management changes and has terminated the services of Preston Maddin as Chief Financial Officer and Dwayne Sorobey as Vice President Finance and Communications of the Corporation and its wholly-owned subsidiary Prevent Health Care International Limited. Mr. Sorobey has also resigned as a director and officer of My-Cardia (USA) Inc.

FOR FURTHER INFORMATION, PLEASE CONTACT:

David Rubin
President and Chief Executive Officer
eMail: drubin@prevent-healthcare.com
Mobile: +1-972-54-4687142

SOURCE: Prevent Health Care International Limited

View source version on accesswire.com:
https://www.accesswire.com/545860/Prevent-Announces-Management-Changes-and-Termination-of-Services-of-CFO-and-VP-Finance-and-Communications

user

Recent Posts

TEN RESEARCHERS HONORED AT ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE

TORONTO, July 27, 2025 /PRNewswire/ -- The Alzheimer's Association® will present 10 scientific awards at…

2 minutes ago

Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop

– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel…

1 day ago

ISS Recommends Shareholders Vote FOR the Merger between Regional Health Properties, Inc. and SunLink Health Systems, Inc.

Atlanta, GA., July 25, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP)…

1 day ago

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

1 day ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”)…

1 day ago

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”)…

1 day ago